Postpartum Hemorrhage (PPH) Treatment Devices Market to Acquire a Value of US$ 909 Million by the end of 2032

The postpartum haemorrhage (PPH) treatment devices market is anticipated to reach a valuation of US$ 777 million in 2022 and grow at a CAGR of 4% to reach US$ 909 million by the end of 2026, according to a new Fact.MR report.

By 2026, it's anticipated that uterine balloon tamponade technology would be valued at US$428 million. The market for PPH treatment devices is anticipated to increase as there are an increasing number of pregnancy-related issues, such as multiple pregnancies and inverted uteruses, which considerably increase the risk of postpartum bleeding or haemorrhage.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7644

Market Participants

• 3RD Stone Design, Inc.
• Bactiguard AB
• Becton, Dickinson, and Company
• C. R. Bard, Inc.
• Cook Medical, Inc.
• Alydia Health
• Revmedx Inc.
• Teleflex Incorporated
• Utah Medical Products, Inc.

Compared to industrialized nations, emerging economies are responsible for a disproportionately greater number of obstetric hemorrhage fatalities. Growing instances of pregnancy-related difficulties, such as multiple pregnancies, large-for-baby births, and inverted uteruses, which significantly raise the risk of postpartum bleeding or hemorrhage, are expected to fuel market growth.

The market is probably going to benefit from rising healthcare costs and ongoing initiatives by the governments of several nations to increase public awareness of these issues. 

Winning Strategy

The market for PPH treatment equipment is still dominated by the top suppliers, despite the entry of several new businesses. To release new and improved products, major market players are investing a lot of money in the R&D of PPH treatment devices.

Increased government initiatives in various nations and attempts to provide effective PPH treatments & equipment for patients in rural areas are anticipated to benefit major market participants. Top companies in the postpartum hemorrhage devices market are emphasizing organic growth initiatives, including new system launches, product approvals, and patents and promotions through events.

Collaborations, acquisitions, and partnerships are examples of inorganic growth tactics in the market. These actions have made it possible for market participants to grow their consumer bases and operations across regions.

• On August 9, 2022, BD (Becton, Dickinson and Company), a top global medical technology company, and Labcorp, a renowned life sciences company, announced a collaboration agreement. This framework will be used to develop, produce, market, and sell flow cytometry-based companion diagnostics (CDx).

Key Emphasize

• Main drivers of the North America PPH treatment devices market include rising awareness among patients & healthcare professionals, high hospital delivery rates, and wide commercial availability of PPH treatment devices.

• Uniject prefilled injection system demand anticipated to grow faster than other products in the market. Uniject is a disposable as well as an auto-disable injectable system.

• Demand for PPH treatment products expected to expand at 4% CAGR from 2022 to 2026.

• Asia Pacific emerging as profitable regional market for postpartum hemorrhage treatment device suppliers.

 Industry Research

• By Product :

  • Uterine Balloon Tamponades

  • Non-pneumatic Anti-shock Garments (NASG)

  • Uniject Prefilled Injection Systems

• By End User :

  • Hospitals

  • Clinics

  • Others

• By Region :

  • North America

  • Latin America

  • Europe

  • East Asia

  • South Asia & Oceania

  • MEA

What makes Fact.MR report stand out from others?

• Fact.MR follows a six-point mechanism known as E.V.O.L.V.E. (Evaluate. Visualize. Overcome. Leverage. Verify. Eradicate.). The report is specially created to assess the COVID-19 impact on the Postpartum hemorrhage (PPH) treatment devices market. This mechanism focuses on almost all the factors in a definite manner to provide the best research report for the market stakeholders.

• Evaluate: A Fact.MR report evaluates every small aspect that can prove to be a growth generator for the Postpartum hemorrhage (PPH) treatment devices market, thus, making it different and special from other reports.

• Visualize: The authors involved in the research activities visualized the post-COVID-19 era so that the key stakeholders of market get an overview and helps them take certain steps to ensure continuous growth during the forecast period.

• Overcome: The report scrutinizes on points that can prove to be an Achilles heel to the Postpartum hemorrhage (PPH) treatment devices market and assists to create strategies to overcome the obstacles that may hinder the growth of the Postpartum hemorrhage (PPH) treatment devices market.

• Leverage: The Postpartum hemorrhage (PPH) treatment devices market can leverage certain aspects that can prove beneficial for the increase in growth rate. Fact.MR covers all the points on which the key stakeholders can leverage upon.

• Verify: Research is done systematically to assure validation of all the aspects covered in the report. All the points are rechecked and verified thoroughly to avoid flaws and fake information.

• Eradicate: Last but not the least, this aspect helps the key stakeholder eradicate all the obstacles that come between the growth rate and the Postpartum hemorrhage (PPH) treatment devices market.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7644